Gencell Ltd (TLV:GNCL)
Israel · Delayed Price · Currency is ILS · Price in ILA 80.00
+2.70 (3.49%)
Aug 24, 2026, 11:09 AM IDT
Gencell Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 33.81 | 34.78 | 17.52 | 26.03 | 17.24 | 1.04 | |
Revenue Growth | 92.82% | 98.56% | -32.71% | 51.02% | 1554.89% | -74.51% |
Cost of Revenue | 41.62 | 38.23 | 36.14 | 35.35 | 26.46 | 6.07 |
Gross Profit | -7.81 | -3.45 | -18.62 | -9.32 | -9.22 | -5.02 |
Selling, General & Admin | 36.56 | 36.19 | 40.4 | 40.19 | 36.56 | 28.2 |
Research & Development | 21.19 | 30.28 | 47.57 | 27.62 | 17.74 | 26.64 |
Operating Expenses | 57.76 | 66.48 | 87.96 | 67.82 | 54.3 | 54.84 |
Operating Income | -65.56 | -69.92 | -106.58 | -77.14 | -63.52 | -59.87 |
Interest Expense | -1.34 | -0.62 | -0.69 | -0.77 | -2.45 | -5.11 |
Interest & Investment Income | 1.22 | 5.84 | 11.57 | 8.81 | 1.09 | - |
Currency Exchange Gain (Loss) | 0.89 | 0.96 | 0.97 | -10.14 | 0.41 | 3.36 |
Other Non Operating Income (Expenses) | 4.39 | 2.74 | -0.81 | 3.21 | -0.93 | 0.43 |
EBT Excluding Unusual Items | -60.41 | -61.01 | -95.54 | -76.04 | -65.39 | -61.19 |
Gain (Loss) on Sale of Assets | -0.6 | -0.13 | - | - | - | - |
Asset Writedown | -5.97 | -9.37 | -6.18 | -52.26 | - | - |
Pretax Income | -66.98 | -70.51 | -101.72 | -128.29 | -65.39 | -61.19 |
Income Tax Expense | 0.24 | 0.27 | 0.21 | 0.67 | 0.2 | 0.06 |
Net Income | -67.22 | -70.78 | -101.92 | -128.96 | -65.6 | -61.25 |
Net Income to Common | -67.22 | -70.78 | -101.92 | -128.96 | -65.6 | -61.25 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 19 | 4 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 19 | 4 |
Shares Change | 1.80% | 1.24% | 0.14% | 13.67% | 424.33% | 160.17% |
EPS (Basic) | -3.05 | -3.25 | -4.73 | -6.00 | -3.47 | -16.98 |
EPS (Diluted) | -3.08 | -3.28 | -4.73 | -6.00 | -3.47 | -16.98 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -44.5 | -69.48 | -98.53 | -84.55 | -44.99 | -34.93 |
Free Cash Flow Per Share | -2.02 | -3.19 | -4.58 | -3.93 | -2.38 | -9.68 |
Gross Margin | -23.10% | -9.92% | -106.29% | -35.81% | -53.50% | - |
Operating Margin | -193.93% | -201.05% | -608.45% | -296.34% | -368.50% | -5747.84% |
Profit Margin | -198.82% | -203.52% | -581.87% | -495.42% | -380.55% | -5880.86% |
Free Cash Flow Margin | -131.62% | -199.78% | -562.48% | -324.80% | -260.99% | -3353.09% |
EBITDA | -60.99 | -69.08 | -105.12 | -76.88 | -62.16 | -58.84 |
EBITDA Margin | -180.38% | -198.62% | - | -295.34% | - | - |
D&A For EBITDA | 4.58 | 0.85 | 1.46 | 0.26 | 1.36 | 1.03 |
EBIT | -65.56 | -69.92 | -106.58 | -77.14 | -63.52 | -59.87 |
EBIT Margin | -193.93% | -201.05% | - | -296.34% | - | - |
Advertising Expenses | - | 2.66 | 3.32 | 2.28 | 0.92 | 0.62 |